REKVINA LABORATORIES
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Rekvina Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
4.96₹ 0.92
As on Feb 9, 2026, 4:01 PM IST
Rekvina Laboratories Price Performance
Today's LowToday's High
₹19.47₹19.47
₹19.47
52 Weeks' Low52 Weeks' High
₹6.75₹18.55
₹19.47
Open Price
₹19.47
Prev. Close
₹18.55
Volume
6,985
Over the last 5 years, the share price of Rekvina Laboratories has gained 36.10% CAGR. Over the past year, the corresponding return has been 175.00%.
Rekvina Laboratories’s current P/E of -49.54x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Rekvina Laboratories Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Rekvina Laboratories | 47.17 | 175.00 | 175.00 | 175.00 | 175.00 | 40.10 | 36.10 |
| Sun Pharmaceutical Industries | 6.87 | -4.37 | 0.70 | 6.63 | -2.57 | 19.23 | 21.85 |
| Divi's Laboratories | 1.03 | -7.91 | -8.11 | -0.27 | -0.39 | 30.55 | 10.09 |
| Torrent Pharmaceuticals | 0.97 | -2.28 | 11.69 | 11.15 | 22.66 | 37.59 | 23.72 |
| Cipla | 1.40 | -8.51 | -10.77 | -9.99 | -8.82 | 9.19 | 9.63 |
| Dr. Reddy's Laboratories | 4.42 | 2.39 | 5.56 | 5.96 | 2.55 | 12.72 | 5.55 |
| Lupin | 2.76 | -0.14 | 12.12 | 13.57 | 0.50 | 43.25 | 15.62 |
| Zydus Lifesciences | 3.99 | -0.72 | -2.46 | -2.62 | -7.38 | 24.29 | 14.23 |
| Mankind Pharma | -1.81 | -9.74 | -7.81 | -17.92 | -17.15 | 13.58 | 7.94 |
| Aurobindo Pharma | -0.91 | -2.76 | 6.97 | 12.33 | 0.80 | 42.10 | 4.65 |
| Alkem Laboratories | 1.07 | -0.98 | 1.04 | 17.54 | 11.22 | 23.21 | 14.59 |
| Biocon | 2.01 | -3.43 | -1.64 | 2.55 | -3.23 | 16.30 | -1.78 |
| Abbott India | -0.81 | -3.66 | -4.69 | -16.22 | -7.87 | 9.41 | 13.62 |
| Glenmark Pharmaceuticals | -2.23 | -6.68 | 8.65 | -4.43 | 28.04 | 71.29 | 31.42 |
| Laurus Labs | 2.09 | -12.70 | 0.28 | 17.55 | 53.63 | 43.95 | 22.52 |
| GlaxoSmithKline Pharmaceuticals | 4.74 | 2.16 | -3.07 | -6.27 | 13.91 | 26.53 | 11.47 |
| Anthem Biosciences | 12.46 | 2.67 | -3.42 | -10.30 | -7.83 | -2.68 | -1.62 |
| Ipca Laboratories | -0.97 | -3.89 | 10.08 | 4.61 | -3.40 | 19.14 | 8.42 |
| Ajanta Pharma | 2.52 | 0.03 | 13.00 | 9.11 | 6.12 | 33.94 | 18.79 |
| Gland Pharma | 2.15 | 10.35 | 1.32 | -3.67 | 24.33 | 12.94 | -4.08 |
Over the last one year, Rekvina Laboratories has gained 175.00% compared to peers like Sun Pharmaceutical Industries (-2.57%), Divi's Laboratories (-0.39%), Torrent Pharmaceuticals (22.66%). From a 5 year perspective, Rekvina Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (21.85%) and Divi's Laboratories (10.09%).
Rekvina Laboratories Financials
Rekvina Laboratories Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 16.87 | 16.84 |
| 10 | 14.55 | 14.89 |
| 20 | 11.1 | 12.12 |
| 50 | 6.98 | 8.64 |
| 100 | 6.12 | 7.04 |
| 200 | 5.65 | 6.64 |
Rekvina Laboratories Share Holding Pattern
In the latest quarter, Rekvina Laboratories remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding unchanged at 58.72% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Rekvina Laboratories Corporate Actions
Date Time | Announcement |
|---|---|
| Feb 06, 2026, 11:26 PM IST | Rekvina Laboratories - Board Meeting Outcome for Outcome Of The Board Meeting Held On 06Th February, 2026 |
| Jan 29, 2026, 9:45 PM IST | Rekvina Laborato - Announcement under Regulation 30 (LODR)-Change in Directorate |
| Jan 29, 2026, 9:27 PM IST | Rekvina Laborato - Announcement under Regulation 30 (LODR)-Change in Directorate |
| Jan 29, 2026, 8:08 PM IST | Rekvina Laborato - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 6Th February, 2026 |
| Jan 09, 2026, 7:19 PM IST | Rekvina Laborato - Announcement under Regulation 30 (LODR)-Change in Directorate |
About Rekvina Laboratories
Rekvina Laboratories Ltd. is a Public Limited Listed company incorporated on 01/11/1988 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24231GJ1988PLC011458 and registration number is 011458. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 3.01 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressParadise Complex 328-329, 3rd Floor, Sayajigunj, Vadodra Gujarat 390005
- Contact
Management
- Mr. Amit Mukesh ShahManaging Director
- Mrs. Iiaben PathakNon Exe.Non Ind.Director
- Mr. Chetanbhai PatelIndependent Director
- Mr. Dhruvalkumar PatelIndependent Director
- Mr. Surbhit ShahExecutive Director & CFO
FAQs on Rekvina Laboratories Share Price
What is the share price of Rekvina Laboratories?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Rekvina Laboratories is ₹19.47 as on Feb 09, 2026.
What kind of stock is Rekvina Laboratories?
The Rekvina Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Rekvina Laboratories?
The market cap of Rekvina Laboratories is ₹11.74 Cr as on Feb 09, 2026.
What are today's High and Low prices of Rekvina Laboratories?
Today’s highest and lowest price of Rekvina Laboratories are ₹19.47 and ₹19.47.
What are the 52 Week High and 52 Week Low of Rekvina Laboratories?
The 52-week high/low is the highest and lowest price at which Rekvina Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Rekvina Laboratories is ₹18.55 and 52-week low of Rekvina Laboratories is ₹6.75 as on Feb 09, 2026.
How has the Rekvina Laboratories performed historically in terms of returns?
The Rekvina Laboratories has shown returns of 4.96% over the past day, 175.0% for the past month, 175.0% over 3 months, 175.0% over 1 year, 40.1% across 3 years, and 36.1% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Rekvina Laboratories?
P/E ratio of and PB ratio of Rekvina Laboratories are -49.54 and -15.59 on Feb 09, 2026. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse